Complete Guide to Pravastatin EHC Model Pharmacokinetics
Overview
Pravastatin EHC Model is a Statin used in the Cardiology therapeutic area. It is indicated for Hypercholesterolemia. Pravastatin PopPK model with 8-transit Erlang absorption and enterohepatic circulation. Based on Ide et al. — shows characteristic double-peak PK profile.
Mechanism of Action
Pravastatin EHC Model exerts its pharmacological effect by targeting HMG-CoA Reductase. As a Statin, it modulates this target to achieve therapeutic efficacy in Hypercholesterolemia. Understanding the target engagement is critical for interpreting the pharmacokinetic-pharmacodynamic (PK/PD) relationship and optimizing dosing regimens.
Key Pharmacokinetic Parameters
The following parameters are derived from published PopPK models for Pravastatin EHC Model:
| Parameter | Value |
|---|---|
| tg | 3.61 h (gallbladder emptying time) |
| K12 | 0.183 h⁻¹ |
| K21 | 0.436 h⁻¹ |
| MTT | 0.660 h |
| CL F | 139 L/h |
| V1 F | 253 L |
| Ndepot | 8 |
| Frel SLCO1B1 het | 1.5 |
| Frel SLCO1B1 hom | 1.95 |
Parameters represent typical population estimates from published literature. Individual values may vary.
Dosing & Administration
Pravastatin EHC Model is administered via the Oral route. Oral administration involves absorption from the gastrointestinal tract, and bioavailability may be affected by food intake, formulation, and first-pass metabolism.
Dosing recommendations should always follow approved prescribing information. The interactive simulator allows you to explore different dosing scenarios and their impact on drug exposure metrics such as AUC, Cmax, and Ctrough.
Clinical Considerations
In the Cardiology therapeutic area, for the treatment of Hypercholesterolemia, understanding the pharmacokinetics of Pravastatin EHC Model is essential for dose optimization and therapeutic drug monitoring. Key clinical factors that may affect Pravastatin EHC Model pharmacokinetics include:
- •Body weight and body composition
- •Renal and hepatic function
- •Drug-drug interactions and concomitant medications
- •Age, sex, and genetic polymorphisms
Interactive Pravastatin EHC Model PK Simulator
Explore Pravastatin EHC Model pharmacokinetics interactively. Adjust doses, dosing intervals, and patient covariates to visualize concentration-time profiles in real time.
Frequently Asked Questions
What is the half-life of Pravastatin EHC Model?
The elimination half-life of Pravastatin EHC Model depends on patient-specific factors. Use our interactive Pravastatin EHC Model PK simulator to explore concentration-time profiles and estimate half-life under different dosing scenarios.
How is Pravastatin EHC Model administered?
Pravastatin EHC Model is administered via the Oral route. It is indicated for Hypercholesterolemia. As a Statin, dosing regimens should follow approved prescribing information and clinical guidelines.
What are the key PK parameters of Pravastatin EHC Model?
Key pharmacokinetic parameters for Pravastatin EHC Model include clearance (CL), volume of distribution (Vd), and elimination half-life. See the PK Parameters section above for specific values from published models.
Can I simulate Pravastatin EHC Model dosing scenarios for free?
Yes! PKPDBuilder offers a completely free, interactive Pravastatin EHC Model PK simulator based on published pharmacometric models. No login required. Use it to explore different doses, dosing intervals, and patient covariates.
⚠️ Disclaimer
This guide is for research and educational purposes only. It is not intended for clinical decision-making or patient dosing. Parameters are derived from published literature and represent population estimates. Always consult approved prescribing information for clinical use.